Efficacy and safety of botulinum toxin in treating scleroderma-associated raynaud's phenomenon: a systematic review and meta-analysis

Arch Dermatol Res. 2024 Apr 17;316(5):122. doi: 10.1007/s00403-024-02864-x.
No abstract available

Keywords: Botulinum Toxin; Raynaud’s phenomena; Scleroderma; Systemic Sclerosis.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Letter

MeSH terms

  • Botulinum Toxins* / therapeutic use
  • Humans
  • Raynaud Disease* / drug therapy
  • Skin Diseases* / complications

Substances

  • Botulinum Toxins